MDedge Hematology and Oncology

MDedge Hematology & Oncology provides crucial, up-to-date, evidence-driven information that is essential for hematologist-oncologists and medical oncologists. Its user-friendly and interactive formats allow busy professionals to easily stay informed and gain insights necessary for delivering high-quality care that enhances patient outcomes.

International, Trade/B2B

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#80128

United States

#24476

Health/Health

#584

Traffic sources

Monthly visitors

Articles

Policy & Practice

2 days ago | mdedge.com | Joyce Frieden

Fla. Ruling Affects Levothyroxine RxA ruling by a Florida administrative law judge means pharmacists in that state now are free to substitute generic levothyroxine sodium for brand-name formulations of the drug. The January decision that removed Synthroid, Levoxyl, Levothroid, and Unithroid from the negative formulary list came in response to a petition last August by Mylan Inc., which markets a generic form of levothyroxine.
Policy & Practice

3 days ago | mdedge.com | Joyce Frieden

Feds Launch Sickle Cell CampaignThe National Institute of Diabetes and Digestive and Kidney Diseases is spearheading a campaign to stress the importance of careful hemoglobin A1c testing in people with diabetes who have sickle cell trait or similar blood disorders.
Exercise Can Help Protect Against Cancer Fatigue, Depression

1 week ago | mdedge.com | Megan Brooks

FROM AACR 2025Lingering fatigue and depression are more common among women than men cancer survivors and often lead to a decrease in recreational physical activities in all patients, new data showed.
Single Antiplatelet After TAVR Lowers Risk

1 week ago | mdedge.com | Carolyn Brown

FROM SCAI 2025Patients who received a single antiplatelet drug therapy — usually aspirin — after transcatheter aortic valve replacement (TAVR) had about half the risk of dying in the subsequent 6 months compared with patients who received dual antiplatelet drug therapy. The findings were similar in men and women and in patients with and without coronary artery disease.
Weighing children in school: No good can come of it

1 week ago | mdedge.com | Yoni Freedhoff

The United Kingdom’s National Obesity Forum has apparently decided that returning to school this fall in the middle of a pandemic isn’t stressful enough for kids, and is recommending that its National Child Measurement Programme be expanded to have 4- to 5-year-old and 10- to 11-year-old children weighed when they return to the classroom – and then weighed again in the spring – in a bid to tackle COVID-19–related gains.
Bridging the Knowledge-Action Gap in Skin Cancer Prevention Among US Military Personnel

1 week ago | mdedge.com | Sophia Anderson |serena zhang |Angela Crotty |Nicholas Logemann

Skin cancer is a major health concern for military service members, who experience notably higher incidence rates than the general population.1 Active-duty military personnel are particularly vulnerable to prolonged sun exposure due to deployments, specialized training, and everyday outdoor duties.1 Despite skin cancer being the most commonly diagnosed malignancy in active-duty service members,2 tracking and documenting the quantity and diversity of these risk factors remain limited.
Key Blood Proteins Predict MASLD Up to 16 Years in Advance

2 weeks ago | mdedge.com | Nancy A. Melville

FROM DDW 2025SAN DIEGO – The presence of five key proteins in the blood was strongly associated with the development of metabolic dysfunction-associated steatotic liver disease (MASLD) as much as 16 years before symptoms appeared, new research showed. “This represents the first high-performance, ultra-early (16 years) predictive model for MASLD,” said first author Shiyi Yu, MD, resident physician in the department of gastroenterology, Guangdong Provincial People’s Hospital in China.
Four Key Genes Linked to Worse Gastric Cancer Outcomes

2 weeks ago | mdedge.com | Nancy A. Melville

FROM DDW 2025SAN DIEGO – Patients carrying at least one of the four key genes show a significantly increased risk for disease recurrence and mortality in gastric cancer, according to new research that potentially paves the way for precision oncology and improved targeting of therapies.
Auto-Brewery Syndrome Explained: New Patient Cohort Identifies Culprit Bacteria, Fermentation

3 weeks ago | mdedge.com | Christine Kilgore

FROM GMFH 2025WASHINGTON — When a published case of auto-brewery syndrome (ABS) in China — caused by Klebsiella pneumoniae — received widespread publicity in 2019, patients reacted, sending emails to lead author Jing Yuan, in Beijing, China. Many of these inquiries were from patients in the United States who believed they might have ABS. “Can you check to see if I have ABS?” patients asked Yuan.
Computer-Aided Colonoscopy Not Ready for Prime Time: AGA Clinical Practice Guideline

3 weeks ago | mdedge.com | Diana Swift

FROM GASTROENTEROLOGYAn AGA multidisciplinary panel has reached the conclusion that no recommendation can be made for or against the use of computer-aided detection (CADe)–assisted colonoscopy for colorectal cancer (CRC), the third most common cause of cancer mortality in the United States. The systematic data review is a collaboration between AGA and The BMJ’s MAGIC Rapid Recommendations. The BMJ issued a separate recommendation against CADe shortly after the AGA guideline was published.